← Leaderboards
Jianguo Huang
Providence Health & Services - Oregon
$486,000
Attributed
$486,000
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $162K · FY2022–24$200K$150K$100K$50K$0
'22
'23
'24
Funding mix
By agency
NIH$486,000 · 1
By mechanism
K22$486,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Human Data”
- Supriya Menezes · The Emmes Company, Llc$25,277,032
- Suma Babu · Massachusetts General Hospital$25,163,692
- Sabrina Paganoni · Massachusetts General Hospital$25,163,692
- Calvin Proffitt · Leidos Biomedical Research, Inc.$19,442,847
- Maximilian Haeussler · University Of California Santa Cruz$13,899,136
- Cynthia M Visness · Rho Federal Systems Division, Inc.$13,531,908
Research focus
Human DataImmunohistochemistryHigh-Throughput Rna SequencingChemotherapyCodeBiologyCellsGrantDesignDiagnosisDistantFat GeneFoundationsFunding AgencyComplexGenesCrispr/Cas TechnologyAdultGeneticGenetically Engineered MouseGenetic ScreeningGenome-WideGenomicsImproved Outcome
Grant awards (3)
DISSECTING THE ROLES OF FAT1 AND NEAT1 IN SOFT TISSUE SARCOMA DEVELOPMENT AND METASTASIS USING NOVEL IN VIVO SARCOMA MODELS$162,000
K22 · FY2024 · CA · contact PI
DISSECTING THE ROLES OF FAT1 AND NEAT1 IN SOFT TISSUE SARCOMA DEVELOPMENT AND METASTASIS USING NOVEL IN VIVO SARCOMA MODELS$162,000
K22 · FY2023 · CA · contact PI
DISSECTING THE ROLES OF FAT1 AND NEAT1 IN SOFT TISSUE SARCOMA DEVELOPMENT AND METASTASIS USING NOVEL IN VIVO SARCOMA MODELS$162,000
K22 · FY2022 · CA · contact PI